Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Living Carbon is a private public benefit company developing and deploying genetically engineered trees and reforestation projects to increase carbon capture, restore degraded land, and generate carbon removal credits. The company combines plant biotechnology, forestry operations, and carbon project development, with a particular focus on abandoned mine lands and degraded agricultural land in the United States. Its commercial offerings include certified carbon credits, bespoke sequestration projects, and biomass-oriented woody crop solutions. Living Carbon has also advanced large carbon offtake agreements, including a major deal with Microsoft, while continuing R&D on photosynthesis-enhanced and metal-accumulating trees.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Living Carbon.